Navigation Links
Atrium Recognized by New Hampshire Bio/Medical Council
Date:10/18/2010

HUDSON, N.H., Oct. 18 /PRNewswire/ -- The New Hampshire Bio/Medical Council held its 2nd Annual Awards Dinner on October 14, 2010 at the Wentworth-By-The-Sea Country Club in Rye, NH. During the evening, the Bio/Medical Council awarded Atrium Medical Corporation of Hudson, NH the NH Bio/Medical Council Business of the Year Award. In attendance to accept the award were Ted Karwoski, Chief Operating Officer and Steve Vail, Group VP of Global Marketing.

The dinner also honored New Hampshire's senator, Judd Gregg and his long term support of the life sciences industry by establishing the Judd Gregg New Hampshire Bio/Medical Internship Program. This program is designed to provide summer internships to students or recent graduates who are considering careers in the life sciences industry. The number of interns will vary from year to year depending on demand and funding. The Bio/Medical sector is a viable and growing sector of New Hampshire businesses and with the Internship Program, the Council hopes to keep talented graduates here in New Hampshire.

The NH Bio/Medical Council, along with the efforts of Atrium Medical Corporation, strives to promote economic development in New Hampshire with long term goals in education, business development, job creation and retention. Established in 1999, the Council has worked steadily to establish a strong identity for the industry in New Hampshire and to network the academic, industry and government participants into a cohesive whole. In 2003, the Council began work to establish three consortiums for human resources, service providers and purchasing to support companies and affiliates in our industry.

Atrium is honored to be recognized by this organization and to receive this award.

About Atrium

Atrium's vast expertise in medical device technologies for the treatment of coronary and vascular disease, chest trauma, hernia and soft tissue injury has brought a number of breakthrough advances in several diversified healthcare markets including interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and hernia repair. Maintaining a commitment to the latest ISO13485 Quality Standards, late breaking advancements in manufacturing and automation, cell biology and biomaterial research, Atrium continues to excel in those healthcare segments that require more advanced surgical intervention for life sustaining patient care. For more information please call Atrium's Marketing Communications Dept. at 1-800-370-7899 or visit Atrium's website at www.atriummed.com.


'/>"/>
SOURCE Atrium Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Atrium Recognized by Business NH Magazine
2. Atrium Responds to Bard Suit
3. Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent
4. Point-of-Care Partners Recognized for Role in Managing SEMI
5. HistoRx Recognized as a 2010 Company to Watch by the Connecticut Technology Council
6. Duluth-Area Plasma Donors to be Recognized for Lifesaving Contribution in Fight Against Rare Diseases
7. Precision Therapeutics President and CEO Sean McDonald Recognized as a Leading Business Executive and Recipient of 2010 Pacesetters Award
8. Lilly Recognized with World Business and Development Award for Tuberculosis Initiative
9. Qosina Recognized for Second Consecutive Year on the Inc. 5000 List
10. Biohearts MyoCell Recognized as one of the Breakthrough Developments of 2010
11. Baxa Corporation Recognized for Pharmacy Automation Leadership and Business Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)...   Arena Pharmaceuticals, Inc. (NASDAQ: ... in the ralinepag phase 2 trial.  Ralinepag is an ... for the treatment of pulmonary arterial hypertension (PAH). The ... "This marks an important step in the development ... on our pipeline," said Amit Munshi , Arena,s ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 According to ... in more than one-third (38%) of patients with non-small cell ... epidermal growth factor receptor (EGFR) genetic mutation status. The findings ... ( LBA ID #6067 #P3.02b ) at the ... Vienna, Austria . The survey results revealed ...
(Date:12/7/2016)... LONDON , Dec. 7,2016  Based ... drug delivery industry, Frost & Sullivan recognizes ... Frost & Sullivan Award for Enabling Technology ... plug the loopholes in traditional drug delivery ... and liquid microneedle-based drug delivery technologies, Memspatch ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... Augustine ... services to families and business owners in the greater Dallas metropolitan area, is ... Dallas Fallen Officer Foundation. , Established in 2009 by active police professionals in ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Sharon Kleyne, ... Global Climate Change and Your Health on Voice of America, declared on her radio ... call attention to the fact that when these bullies attack leaders in corporate America, ...
(Date:12/7/2016)... ... 07, 2016 , ... 1105 Media’s Live From program has ... Awards competition. Live From won in the Use of Social Media category. The ... projects undertaken by the media industry’s most innovative marketing professionals. , ...
(Date:12/7/2016)... ... 2016 , ... Maureen McLaughlin, LA.c., a certified acupuncturist, is ... Connecticut (RMACT). McLaughlin brings nearly 20 years of experience with fertility patients to ... their family building goals. Acupuncture helps fertility patients by supporting the ...
(Date:12/7/2016)... Va. (Dec. 3, 2016) , ... (PRWEB) December ... ... nation’s only patient advocacy nonprofit for individuals impacted by cerebral cavernous angiomas, was ... in New Mexico with a patient engagement program. New Mexico has more people ...
Breaking Medicine News(10 mins):